Belite Bio (BLTE) News Today $56.91 -0.34 (-0.59%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 9.2% in JanuaryBelite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a significant drop in short interest in January. As of January 31st, there was short interest totalling 63,800 shares, a drop of 9.2% from the January 15th total of 70,300 shares. Based on an average trading volume of 59,400 shares, the days-to-cover ratio is currently 1.1 days.February 17, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Trading Up 7.8% - Here's What HappenedBelite Bio (NASDAQ:BLTE) Trading Up 7.8% - Here's What HappenedFebruary 11, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Trading Down 4.7% - Should You Sell?Belite Bio (NASDAQ:BLTE) Shares Down 4.7% - Here's What HappenedFebruary 10, 2025 | marketbeat.comBelite Bio to sell 258,309 shares at $58.07 in registered direct offeringFebruary 6, 2025 | markets.businessinsider.comBelite Bio: The Picture Is Still UnclearFebruary 6, 2025 | seekingalpha.comBelite Bio Announces Registered Direct Offering of $15 MillionFebruary 5, 2025 | globenewswire.comBelite Bio FY2024 EPS Forecast Lifted by Leerink PartnrsBelite Bio, Inc (NASDAQ:BLTE - Free Report) - Investment analysts at Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for shares of Belite Bio in a report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings ofJanuary 31, 2025 | marketbeat.comJPMorgan Chase & Co. Grows Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE)JPMorgan Chase & Co. increased its holdings in shares of Belite Bio, Inc (NASDAQ:BLTE - Free Report) by 7,122.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,356 shares of the company's stock afterJanuary 31, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Short Interest Down 60.3% in JanuaryBelite Bio, Inc (NASDAQ:BLTE - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 80,400 shares, a drop of 60.3% from the December 31st total of 202,300 shares. Based on an average daily volume of 72,900 shares, the short-interest ratio is currently 1.1 days.January 29, 2025 | marketbeat.comBelite Bio files automatic mixed securities shelfJanuary 29, 2025 | markets.businessinsider.comBelite Bio (NASDAQ:BLTE) Shares Gap Up on Analyst UpgradeBelite Bio (NASDAQ:BLTE) Shares Gap Up After Analyst UpgradeJanuary 22, 2025 | marketbeat.comCantor Fitzgerald Forecasts Belite Bio FY2025 EarningsBelite Bio, Inc (NASDAQ:BLTE - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Belite Bio in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Kim forecasts that the company will post earnings ofJanuary 22, 2025 | marketbeat.comBreakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE)January 21, 2025 | finance.yahoo.comBenchmark sees growth for Belite Bio shares, highlights Tinlarebant's promise in rare diseasesJanuary 21, 2025 | msn.comBenchmark Issues Positive Forecast for Belite Bio (NASDAQ:BLTE) Stock PriceBenchmark boosted their target price on shares of Belite Bio from $57.00 to $79.00 and gave the stock a "buy" rating in a research report on Tuesday.January 21, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Up 5.4% - Still a Buy?Belite Bio (NASDAQ:BLTE) Trading Up 5.4% - Here's WhyJanuary 17, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Here's WhyBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Here's What HappenedJanuary 16, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Sees Large Decline in Short InterestBelite Bio, Inc (NASDAQ:BLTE - Get Free Report) saw a large decrease in short interest in December. As of December 31st, there was short interest totalling 80,400 shares, a decrease of 60.3% from the December 15th total of 202,300 shares. Based on an average daily volume of 72,900 shares, the short-interest ratio is currently 1.1 days.January 14, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Down 4.2% - Should You Sell?Belite Bio (NASDAQ:BLTE) Trading Down 4.2% - Here's WhyJanuary 3, 2025 | marketbeat.comShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Declines By 12.9%Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 202,300 shares, a decline of 12.9% from the November 30th total of 232,300 shares. Based on an average trading volume of 72,000 shares, the short-interest ratio is presently 2.8 days.December 30, 2024 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Gap Up - Here's What HappenedBelite Bio (NASDAQ:BLTE) Shares Gap Up - What's Next?December 6, 2024 | marketbeat.comBelite Bio (NASDAQ:BLTE) Shares Down 3.4% - Time to Sell?Belite Bio (NASDAQ:BLTE) Shares Down 3.4% - Here's WhyNovember 29, 2024 | marketbeat.comLin BioScience Receives U.S. FDA Fast Track Designation For LBS-007November 27, 2024 | globenewswire.comBelite Bio (NASDAQ:BLTE) Shares Down 4.5% - Here's What HappenedBelite Bio (NASDAQ:BLTE) Trading Down 4.5% - Here's What HappenedNovember 22, 2024 | marketbeat.comBelite Bio: Interesting Science, But Quite A Few WorriesNovember 20, 2024 | seekingalpha.comCantor Fitzgerald Predicts Weaker Earnings for Belite BioBelite Bio, Inc (NASDAQ:BLTE - Free Report) - Equities researchers at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for shares of Belite Bio in a research note issued on Wednesday, November 13th. Cantor Fitzgerald analyst J. Kim now forecasts that the company will post earniNovember 18, 2024 | marketbeat.comFY2024 EPS Estimates for Belite Bio Lowered by HC WainwrightBelite Bio, Inc (NASDAQ:BLTE - Free Report) - Investment analysts at HC Wainwright reduced their FY2024 earnings estimates for shares of Belite Bio in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst Y. Chen now expects that the company will posNovember 18, 2024 | marketbeat.comShort Interest in Belite Bio, Inc (NASDAQ:BLTE) Decreases By 13.5%Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the recipient of a large drop in short interest in October. As of October 31st, there was short interest totalling 234,000 shares, a drop of 13.5% from the October 15th total of 270,600 shares. Based on an average trading volume of 52,000 shares, the days-to-cover ratio is presently 4.5 days.November 16, 2024 | marketbeat.comBelite Bio price target raised to $110 from $60 at MaximNovember 16, 2024 | markets.businessinsider.comBelite Bio (NASDAQ:BLTE) Given New $110.00 Price Target at Maxim GroupMaxim Group raised their price objective on shares of Belite Bio from $60.00 to $110.00 and gave the company a "buy" rating in a research note on Friday.November 15, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)November 15, 2024 | markets.businessinsider.comBelite Bio’s Promising Clinical Trials and Strong Financial Position Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comBelite Bio Advances in Retinal Disease TrialsNovember 13, 2024 | markets.businessinsider.comBelite Bio price target raised to $100 from $60 at H.C. WainwrightNovember 13, 2024 | markets.businessinsider.comBelite Bio, Inc: Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNovember 13, 2024 | finanznachrichten.deInsights into Belite Bio's Upcoming EarningsNovember 13, 2024 | benzinga.comBelite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNovember 13, 2024 | markets.businessinsider.comBelite Bio, Inc. (BLTE) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comBelite Bio, Inc 2024 Q3 - Results - Earnings Call PresentationNovember 12, 2024 | seekingalpha.comBelite Bio (BLTE) Scheduled to Post Earnings on TuesdayBelite Bio (NASDAQ:BLTE) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports.November 6, 2024 | marketbeat.comBelite Bio Offers New Warrant Opportunities to InvestorsNovember 5, 2024 | markets.businessinsider.comBelite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial ResultsNovember 5, 2024 | globenewswire.comBelite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Here's What HappenedBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Still a Buy?November 4, 2024 | marketbeat.comBelite Bio Announces Exercise of Warrants for US$28.75 Million Gross ProceedsNovember 3, 2024 | globenewswire.comBelite Bio (NASDAQ:BLTE) Reaches New 12-Month High - What's Next?Belite Bio (NASDAQ:BLTE) Hits New 1-Year High - Still a Buy?October 24, 2024 | marketbeat.comBelite Bio (NASDAQ:BLTE) Stock Price Up 4% - Should You Buy?Belite Bio (NASDAQ:BLTE) Stock Price Up 4% - Time to Buy?October 23, 2024 | marketbeat.comBelite Bio (NASDAQ:BLTE) Reaches New 1-Year High - Here's What HappenedBelite Bio (NASDAQ:BLTE) Reaches New 1-Year High - Time to Buy?October 18, 2024 | marketbeat.comBelite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingOctober 15, 2024 | markets.businessinsider.comBelite Bio to Participate in the Maxim Group 2024 Healthcare Virtual SummitOctober 8, 2024 | finance.yahoo.comBelite Bio (NASDAQ:BLTE) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.com Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address BLTE Media Mentions By Week BLTE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLTE News Sentiment▼1.500.60▲Average Medical News Sentiment BLTE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLTE Articles This Week▼12▲BLTE Articles Average Week Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RVMD News LEGN News BBIO News AXSM News BPMC News TLX News ELAN News LNTH News NUVL News CYTK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLTE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLTE Stock Alerts